Evaluating strategies to reduce unnecessary heart imaging tests for stable chest pain
Official title: Optimal Evaluation of Stable Chest Pain to Reduce Unnecessary Utilization of Cardiac Imaging Testing
Run by Tianjin Chest Hospital · NCT05640752 · Data updated 2026-11-12
This study is testing two different ways to see if they can help doctors better identify patients with stable chest pain who don’t need unnecessary heart imaging tests.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 90 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Tianjin Chest Hospital Academic / other |
| Locations | 4 sites (Beijing, Beijing Municipality and 3 other locations) |
| Status | Recruiting |
| Started | December 11, 2023 |
| Main results expected | December 11, 2024 |
| Study ends | December 11, 2025 |
| Registry record updated | December 24, 2024 |
| Trial ID | NCT05640752 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 30 and older with stable chest pain suggestive of chronic coronary syndrome and no history of coronary artery disease.
✕Probably not a fit
Patients with a history of coronary artery disease, clinically unstable conditions, or those who have undergone cardiac imaging within the past year may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The OPERATE trial aims to improve the evaluation of patients with stable chest pain suggestive of chronic coronary syndrome by comparing two diagnostic strategies based on current guidelines. This multicenter, randomized controlled trial will include 800 subjects who will be assigned to either the NICE or ESC strategy to determine which approach better identifies low-risk patients who may not benefit from coronary computed tomography angiography (CCTA). The primary goal is to assess the rates of CCTA without obstructive coronary artery disease (CAD) and to evaluate the safety of both strategies over a one-year follow-up period. By optimizing diagnostic strategies, the study seeks to minimize unnecessary imaging tests and improve patient management.
Why it matters
Potential benefit: If successful, this study could lead to more accurate identification of low-risk patients, reducing unnecessary imaging tests and associated healthcare costs.
How similar studies have gone: Previous studies have explored similar diagnostic strategies, but this trial aims to provide prospective data on their effectiveness in clinical practice.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria 1. SCP or equivalenta suggestive of CCS and clinically stability 2. No history of CAD (prior myocardial infarction, CR or any CAD documented by previous CIT) 3. Age ≥30 years 4. Willing and able to provide informed consent Exclusion criteria 1. Prior CIT within 1 year prior to randomization 2. Clinically instability (e.g. cardiogenic shock, ACS, severe arrhythmias or NYHA III or IV heart failure) 3. Non-sinus rhythm 4. Concomitant participation in another clinical trial 5. Complex structural heart disease 6. Non-cardiac illness with life expectancy \< 2 years 7. Allergy to iodinated contrast agent 8. Estimated glomerular filtration rate\<60 ml/min/1.73m2 within 90 days 9. Body mass index \>35kg/m2 10. Expressing a clear preference for undergoing CIT or not 11. Pregnancy
Where it's running
-
Beijing Chaoyang Hospital
Beijing, Beijing Municipality, China Recruiting -
Hebei Petrochina Central Hospital
Lanfang, Hebei, China Recruiting -
Tianjin First Central Hospital
Tianjin, Tianjin Municipality, China Recruiting -
Tianjin Chest Hospital
Tianjin, China Recruiting
Study contacts
- Principal investigator: Jia Zhou, MD — Tianjin Chest Hospital
- Study coordinator: Jia Zhou, MD
- Email: zhoujiawenzhang@126.com
- Phone: +8615522485560
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
IVUS-Guided Left Main Stenting: IVUS-Guided vs Trained-Eye Approach
This trial tests whether using IVUS to guide left main bifurcation stenting is as good as using an angiography-driven, experience-based approach by an IVUS-savvy operator.
-
Can CZT-SPECT/CT quantify myocardial tracer uptake to match PET measurements in coronary artery disease?
This study tests whether CZT-SPECT/CT can quantify heart blood flow at rest and stress and see if the results align with PET measurements for people with coronary artery disease.
-
Ultrasound vs CT calcium scoring to reclassify symptomatic chest pain
This study tests whether carotid ultrasound can reclassify risk in adults with chest pain and suspected chronic coronary syndrome, compared with the CT calcium score.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.